These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 20921630)

  • 21. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lisuride treatment of Alzheimer's disease. A preliminary placebo-controlled clinical trial of safety and therapeutic efficacy.
    Claus JJ; de Koning I; van Harskamp F; Breteler MM; Voet B; Gutzmann H; Dahlke F; van der Cammen T; Hofman A
    Clin Neuropharmacol; 1998; 21(3):190-5. PubMed ID: 9617511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial.
    Vena GA; Cassano N; D'Argento V; Milani M
    Br J Dermatol; 2006 Feb; 154(2):353-6. PubMed ID: 16433809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial.
    Kemmerich B
    Arzneimittelforschung; 2007; 57(9):607-15. PubMed ID: 17966760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD; Ghent C; Grant D; Horbay GL; McDougal J; David Colby W
    Transplantation; 2003 Sep; 76(6):977-83. PubMed ID: 14508365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term treatment of pityrosporum folliculitis: a double blind placebo-controlled study.
    Parsad D; Saini R; Negi KS
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):188-90. PubMed ID: 9784054
    [No Abstract]   [Full Text] [Related]  

  • 32. Ciprofloxacin therapy in chronic folliculitis of legs.
    Balachandran C; Malpani S; Srinivas CR
    Indian J Dermatol Venereol Leprol; 1995; 61(4):212-3. PubMed ID: 20952957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pityrosporum (Malassezia) folliculitis in Saudi Arabia--diagnosis and therapeutic trials.
    Abdel-Razek M; Fadaly G; Abdel-Raheim M; al-Morsy F
    Clin Exp Dermatol; 1995 Sep; 20(5):406-9. PubMed ID: 8593718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pityrosporum folliculitis: a common disease of the young and middle-aged.
    Bäck O; Faergemann J; Hörnqvist R
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):56-61. PubMed ID: 3980804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pityrosporum folliculitis: treatment with isotretinoin.
    Friedman SJ
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):632-3. PubMed ID: 3469232
    [No Abstract]   [Full Text] [Related]  

  • 36. Current treatment of cutaneous Pityrosporum and Candida-infections.
    Faergemann J
    Acta Derm Venereol Suppl (Stockh); 1986; 121():109-16. PubMed ID: 3459338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Outcomes for Malassezia Folliculitis in theDermatology Department of a University Hospital in Japan.
    Suzuki C; Hase M; Shimoyama H; Sei Y
    Med Mycol J; 2016; 57(3):E63-6. PubMed ID: 27581777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne.
    Yu HJ; Lee SK; Son SJ; Kim YS; Yang HY; Kim JH
    Int J Dermatol; 1998 Oct; 37(10):772-7. PubMed ID: 9802688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases.
    Hald M; Arendrup MC; Svejgaard EL; Lindskov R; Foged EK; Saunte DM;
    Acta Derm Venereol; 2015 Jan; 95(1):12-9. PubMed ID: 24556907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial.
    Ghodsi SZ; Abbas Z; Abedeni R
    Am J Clin Dermatol; 2015 Oct; 16(5):431-7. PubMed ID: 26016699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.